Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.02 USD | -2.90% | -1.57% | -44.16% |
05-07 | Lucien Selce Urges Aurinia Pharmaceuticals Board to Take Action to Enhance Shareholder Value | CI |
05-02 | Transcript : Aurinia Pharmaceuticals Inc., Q1 2024 Earnings Call, May 02, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-44.16% | 716M | |
+3.91% | 109B | |
+10.87% | 105B | |
0.00% | 22.25B | |
-13.14% | 22.09B | |
-8.21% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- AUPH Stock
- News Aurinia Pharmaceuticals Inc.
- RBC Boosts Price Target on Aurinia Pharmaceuticals to $13 From $11 Ahead of Q1 Report, Keeps Outperform, Speculative Risk